** = Publikationen gelistet in SCI/SSCI/Pubmed
** Oleshko, O; Werwitzke, S; Klingberg, A; Witte, T; Eichler, H; Klamroth, R; Holstein, K; Hart, C; Pfrepper, C; Knoebl, P; Greil, R; Neumeister, P; Reipert, BM; Tiede, A
Targets of autoantibodies in acquired hemophilia A are not restricted to factor VIII: data from the GTH-AH 01/2010 study
BLOOD ADV. 2023; 7(1): 122-130.
Doi: 10.1182/bloodadvances.2022008071
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Rieger, K; De Filippi, R; Linden, O; Viardot, A; Hess, G; Lerch, K; Neumeister, P; Stroux, A; Peuker, CA; Pezzutto, A; Pinto, A; Keller, U; Scholz, CW
90-yttrium-ibritumomab tiuxetan as first-line treatment for follicular lymphoma: updated efficacy and safety results at an extended median follow-up of 9.6 years
ANN HEMATOL. 2022;
Doi: 10.1007/s00277-022-04781-3
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Schulz, E; Grumaz, S; Hatzl, S; Gornicec, M; Valentin, T; Huber-Kraßnitzer, B; Kriegl, L; Uhl, B; Deutsch, A; Greinix, H; Krause, R; Neumeister, P
Pathogen Detection by Metagenomic Next-Generation Sequencing During Neutropenic Fever in Patients With Hematological Malignancies.
Open Forum Infect Dis. 2022; 9(8): ofac393
Doi: 10.1093/ofid/ofac393
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Sousa, BB; De Almeida, CR; Barahona, AF; Lopes, R; Martins-Logrado, A; Cavaco, M; Neves, V; Carvalho, LAR; Labao-Almeida, C; Coelho, AR; Bento, ML; Lopes, RMRM; Oliveira, BL; Castanho, MARB; Neumeister, P; Deutsch, A; Vladimer, GI; Krall, N; Joao, C; Corzana, F; Seixas, JD; Fior, R; Bernardes, GJL
Selective Inhibition of Bruton?s Tyrosine Kinase by a Designed Covalent Ligand Leads to Potent Therapeutic Efficacy in Blood Cancers Relative to Clinically Used Inhibitors
ACS PHARMACOL TRANSL. 2022; 5(11): 1156-1168.
Doi: 10.1021/acsptsci.2c00163
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Uhl, B; Prochazka, KT; Pansy, K; Wenzl, K; Strobl, J; Baumgartner, C; Szmyra, MM; Waha, JE; Wolf, A; Tomazic, PV; Steinbauer, E; Steinwender, M; Friedl, S; Weniger, M; Küppers, R; Pichler, M; Greinix, HT; Stary, G; Ramsay, AG; Apollonio, B; Feichtinger, J; Beham-Schmid, C; Neumeister, P; Deutsch, AJ
Distinct Chemokine Receptor Expression Profiles in De Novo DLBCL, Transformed Follicular Lymphoma, Richter's Trans-Formed DLBCL and Germinal Center B-Cells.
Int J Mol Sci. 2022; 23(14):
Doi: 10.3390/ijms23147874
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Neumeister, P; Schulz, E; Pansy, K; Szmyra, M; Deutsch, AJ
Targeting the Microenvironment for Treating Multiple Myeloma.
Int J Mol Sci. 2022; 23(14): 7627
Doi: 10.3390/ijms23147627
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Uhl, B; Prochazka, KT; Fechter, K; Pansy, K; Greinix, HT; Neumeister, P; Deutsch, AJ
Impact of the microenvironment on the pathogenesis of mucosa-associated lymphoid tissue lymphomas.
World J Gastrointest Oncol. 2022; 14(1): 153-162.
Doi: 10.4251/wjgo.v14.i1.153
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Gaksch, L; Huber-Krassnitzer, B; Uhl, B; Bainschab, A; Sifferlinger, IA; Sill, H; Schlenke, P; Rosskopf, K; Beham-Schmid, C; Neumeister, P; Greinix, HT
Autologous stem cell boost for prolonged severe cytopenia after treatment with cd19-car-t-cells for refractory diffuse large b-cell lymphoma -two case reports
BONE MARROW TRANSPL. 2022; 57(SUPPL 1): 141-142.
[Poster]
Web of Science
FullText
** Monch, A; Prochazka, K; Greinix, H; Neumeister, P; Deutsch, A; Uhl, B
Specific clinical, serologic, and histopathologic Parameters are associated with inferior Survival of Patients with primary CNS Lymphoma
ONCOL RES TREAT. 2022; 45(SUPPL 2):61-61.
[Poster]
Web of Science
** Pansy, K; Fechter, K; Wenzl, K; Arra, A; Novak, JP; Szmyra, M; Haingartner, S; Ramsay, AG; Novak, AJ; Greinix, HT; Beham-Schmid, C; Neumeister, P; Deutsch, AJA
Loss of Nr4a1 Causes an Elevated Expression of Co-Inhibitory Receptor:Ligand Axes and Results in a Diminished T Cell-Mediated Lymphoma Cell Killing in Aggressive Lymphoma
BLOOD. 2022; 140: 2038-2039.
Doi: 10.1182/blood-2022-163034
Web of Science
FullText
FullText_MUG
** Rudzki, JD; Jaeger, U; Wolf, D; Petzer, A; Greil, R; Peters, C; Greinix, HT; Attarbaschi, A; Buxhofer-Ausch, V; Girschikofsky, M; Holter, W; Leisch, M; Neumeister, P; Schlenke, P; Schmitt, CA; Schwinger, W; Worel, N; Wohlfarth, P
Stringent Nationwide Selection Criteria for CAR-T Cell Therapy Ensure Favourable Outcome of Patients with LBCL - First Data from the Austrian CAR-T Network
BLOOD. 2022; 140: 6661-6663.
Doi: 10.1182/blood-2022-167603
Web of Science
FullText
FullText_MUG
** Szmyra, MM; Haingartner, S; Jantscher, S; Pansy, K; Uhl, B; Greinix, HT; Neumeister, P; Bernhart, E; Beham-Schmid, C; Dengler, MA; Klosch, B; Deutsch, AJA
The Flavonoid Brusatol Induces Apoptosis in Aggressive Lymphoma Cells and Exhibits Synergistic Effect with Venetoclax
BLOOD. 2022; 140: 4945-4946.
Doi: 10.1182/blood-2022-166678
[Poster]
Web of Science
FullText
FullText_MUG
** Kornauth, C; Pemovska, T; Vladimer, GI; Bayer, G; Bergmann, M; Eder, S; Eichner, R; Erl, M; Esterbauer, H; Exner, R; Felsleitner-Hauer, V; Forte, M; Gaiger, A; Geissler, K; Greinix, HT; Gstöttner, W; Hacker, M; Hartmann, BL; Hauswirth, AW; Heinemann, T; Heintel, D; Hoda, MA; Hopfinger, G; Jaeger, U; Kazianka, L; Kenner, L; Kiesewetter, B; Krall, N; Krajnik, G; Kubicek, S; Le, T; Lubowitzki, S; Mayerhoefer, ME; Menschel, E; Merkel, O; Miura, K; Müllauer, L; Neumeister, P; Noesslinger, T; Ocko, K; Öhler, L; Panny, M; Pichler, A; Porpaczy, E; Prager, GW; Raderer, M; Ristl, R; Ruckser, R; Salamon, J; Schiefer, AI; Schmolke, AS; Schwarzinger, I; Selzer, E; Sillaber, C; Skrabs, C; Sperr, WR; Srndic, I; Thalhammer, R; Valent, P; van, der, Kouwe, E; Vanura, K; Vogt, S; Waldstein, C; Wolf, D; Zielinski, CC; Zojer, N; Simonitsch-Klupp, I; Superti-Furga, G; Snijder, B; Staber, PB
Functional Precision Medicine Provides Clinical Benefit in Advanced Aggressive Hematologic Cancers and Identifies Exceptional Responders.
Cancer Discov. 2022; 12(2):372-387
Doi: 10.1158/2159-8290.CD-21-0538
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Hatzl, S; Kalmar, P; Posch, F; Riedl, JM; Beham-Schmid, C; Prochazka, K; Greinix, H; Schwarz, T; Gstettner, C; Neumeister, P; Schulz, E
Prognostic Value of Baseline and Interim Positron Emission Tomography Markers in Diffuse Large B-cell Lymphoma Patients: A Real-world Perspective.
Hemasphere. 2021; 5(8): e621
Doi: 10.1097/HS9.0000000000000621
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Hatzl, S; Posch, F; Rezai, A; Gornicec, M; Beham-Schmid, C; Magnes, T; Wangner, S; Deutsch, A; Greinix, H; Uhl, B; Prochazka, KT; Egle, A; Greil, R; Melchardt, T; Linkesch, W; Schulz, E; Neumeister, P
Vinorelbine as substitute for vincristine in patients with diffuse large B cell lymphoma and vincristine-induced neuropathy.
Support Care Cancer. 2021; 29(9):5197-5207
Doi: 10.1007/s00520-021-06059-2
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Spindelboeck, W; Halwachs, B; Bayer, N; Huber-Krassnitzer, B; Schulz, E; Uhl, B; Gaksch, L; Hatzl, S; Bachmayr, V; Kleissl, L; Kump, P; Deutsch, A; Stary, G; Greinix, H; Gorkiewicz, G; Högenauer, C; Neumeister, P
Antibiotic use and ileocolonic immune cells in patients receiving fecal microbiota transplantation for refractory intestinal GvHD: a prospective cohort study.
Ther Adv Hematol. 2021; 12:20406207211058333
Doi: 10.1177/20406207211058333
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Staber, PB; Jurczak, W; Greil, R; Vucinic, V; Middeke, JM; Montillo, M; Munir, T; Neumeister, P; Schetelig, J; Stilgenbauer, S; Striebel, F; Dirnberger-Hertweck, M; Weirather, J; Brugger, W; Kelemen, P; Wendtner, CM; Woyach, JA
Tafasitamab combined with idelalisib or venetoclax in patients with CLL previously treated with a BTK inhibitor.
Leuk Lymphoma. 2021; 62(14):3440-3451
Doi: 10.1080/10428194.2021.1964020
Web of Science
PubMed
FullText
FullText_MUG
** Gressenberger, P; Jud, P; Kovacs, G; Kreuzer, S; Brezinsek, HP; Guetl, K; Muster, V; Kolesnik, E; Schmidt, A; Odler, B; Adelsmayr, G; Neumeister, P; Brcic, L; Zenz, S; Weber, K; Gary, T; Brodmann, M; Graninger, WB; Moazedi-Fürst, FC
Rituximab as a Treatment Option after Autologous Hematopoietic Stem Cell Transplantation in a Patient with Systemic Sclerosis.
J Pers Med. 2021; 11(7):
Doi: 10.3390/jpm11070600
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Prochazka, KT; Neumeister, P
Chronic lymphocytic leukaemia-what is new and notable in 2021, with a special focus on COVID-19.
Memo. 2021; 1-4
Doi: 10.1007/s12254-021-00735-z
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Strassl, I; Schreder, M; Steiner, N; Rudzki, J; Agis, H; Künz, T; Müser, N; Willenbacher, W; Petzer, A; Neumeister, P; Krauth, MT
The Agony of Choice-Where to Place the Wave of BCMA-Targeted Therapies in the Multiple Myeloma Treatment Puzzle in 2022 and Beyond.
Cancers (Basel). 2021; 13(18):
Doi: 10.3390/cancers13184701
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Gaksch, L; Pansy, K; Schukoff, T; Greinix, H; Beham-Schmid, C; Neumeister, P; Prochazka, K; Deutsch, A
Distinct expression profile of chemokine receptors is associated with the pathogenesis of follicular lymphoma
ONCOL RES TREAT. 2021; 44: 152-152.
[Poster]
Web of Science
** Greinix, HT; Attarbaschi, A; Girschikofsky, M; Greil, R; Holter, W; Neumeister, P; Peters, C; Petzer, A; Rudzki, J; Schlenke, P; Schmitt, CA; Schwinger, W; Wolf, D; Worel, N; Jaeger, U
Ensuring center quality, proper patient selection and fair access to chimeric antigen receptor T-cell therapy: position statement of the Austrian CAR-T Cell Network.
MEMO-MAG EUR MED ONC. 2020;
Doi: 10.1007/s12254-020-00582-4
[OPEN ACCESS]
Web of Science
FullText
FullText_MUG
** Hatzl, S; Posch, F; Deutsch, A; Beham-Schmid, C; Stöger, H; Greinix, H; Pichler, M; Neumeister, P; Prochazka, KT
Immunohistochemistry for c-myc and bcl-2 overexpression improves risk stratification in primary central nervous system lymphoma.
Hematol Oncol. 2020; 38(3):277-283
Doi: 10.1002/hon.2727
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Ullrich, E; Heidinger, P; Soh, J; Villanova, L; Grabuschnig, S; Bachler, T; Hirschböck, E; Sánchez-Heredero, S; Ford, B; Sensen, M; Rosales, Rodriguez, I; Schwendenwein, D; Neumeister, P; Zurl, CJ; Krause, R; Lorenz, Khol, J; Sensen, CW
Evaluation of host-based molecular markers for the early detection of human sepsis.
J Biotechnol. 2020; 310:80-88
Doi: 10.1016/j.jbiotec.2020.01.013
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Hatzl, S; Posch, F; Schulz, E; Gornicec, M; Deutsch, A; Beham-Schmid, C; Pichler, M; Greinix, H; Sill, H; Zebisch, A; Neumeister, P; Prochazka, KT
The Role of Immunohistochemical Overexpression of p53 as Adverse Prognostic Factor in Primary Testicular Diffuse Large B Cell Lymphoma.
Pathol Oncol Res. 2020; 26(4):2831-2833
Doi: 10.1007/s12253-020-00864-6
Web of Science
PubMed
FullText
FullText_MUG
** Pansy, K; Feichtinger, J; Ehall, B; Uhl, B; Sedej, M; Roula, D; Pursche, B; Wolf, A; Zoidl, M; Steinbauer, E; Gruber, V; Greinix, HT; Prochazka, KT; Thallinger, GG; Heinemann, A; Beham-Schmid, C; Neumeister, P; Wrodnigg, TM; Fechter, K; Deutsch, AJ
The CXCR4-CXCL12-Axis Is of Prognostic Relevance in DLBCL and Its Antagonists Exert Pro-Apoptotic Effects In Vitro.
Int J Mol Sci. 2019; 20(19):
Doi: 10.3390/ijms20194740
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Rawlings, SA; Heldt, S; Prattes, J; Eigl, S; Jenks, JD; Flick, H; Rabensteiner, J; Prüller, F; Wölfler, A; Neumeister, P; Strohmaier, H; Krause, R; Hoenigl, M
Using Interleukin 6 and 8 in Blood and Bronchoalveolar Lavage Fluid to Predict Survival in Hematological Malignancy Patients With Suspected Pulmonary Mold Infection.
Front Immunol. 2019; 10(2):1798-1798
Doi: 10.3389/fimmu.2019.01798
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Rejtő, J; Reitter-Pfoertner, S; Kepa, S; Feistritzer, C; Grundbichler, M; Hörbst, A; Jones, N; Muntean, W; Neumeister, P; Oberbichler, S; Schuster, G; Schwarz, R; Thom, K; Zwiauer, K; Streif, W; Male, C; Pabinger, I
Epidemiology and Treatment of Patients with Haemophilia in Austria-Update from the Austrian Haemophilia Registry.
Hamostaseologie. 2019; 39(3):284-293
Doi: 10.1055/s-0038-1675354
Web of Science
PubMed
FullText
FullText_MUG
** Hatzl, S; Greinix, HT; Kreuzer, P; Schulz, E; Neumeister, P; Scherr, D
A wearable cardioverter defibrillator for prevention of sudden cardiac death in a hematologic patient-a case report
MEMO-MAG EUR MED ONC. 2019; 12(3): 269-271.
Doi: 10.1007/s12254-019-0514-5
[OPEN ACCESS]
Web of Science
FullText
FullText_MUG
** Bohm, A; Lindner, B; Rabitsch, W; Kalhs, P; Worel, N; Clausen, J; Nachbaur, D; Neumeister, P; Panny, M; Keil, F; Russ, G; Eder, S; Isak, E; Zojer, N; Burger, S; Greinix, H
POSTTRANSPLANT OUTCOMES IN ALLOGENEIC AND AUTOLOGOUS STEM CELL TRANSPLANTATION IN AUSTRIA IN COMPARISON TO THE EBMT BENCHMARK: A RETROSPECTIVE ANALYSIS OF THE AUSTRIAN SCT REGISTRY (ASCTR) 2000-2017
TRANSPL INT. 2019; 32: 20-20.
[Oral Communication]
Web of Science
** Lindahl, C; Unterluggauer, J; Pansy, K; Uhl, B; Prochazka, K; Greinix, H; Weniger, M; Kuppers, R; Beham-Schmid, C; Neumeister, P; Haybaeck, J; Deutsch, A
Dysregulated eukaryotic initiation factors may impact on the pathogenesis of primary central nervous system lymphomas
ONCOL RES TREAT. 2019; 42: 82-82.
[Poster]
Web of Science
** Panny, M; Prochazka, K; Nosslinger, T; Neumeister, P; Holzer, K; Bohm, A; Keil, F
Treatment of high risk aggressive B cell lymphomas with DA EPOCH R - a retrospective analysis
ONCOL RES TREAT. 2019; 42: 82-82.
Web of Science
** Pansy, K; Fechter, K; Kargl, J; Wenzl, K; Prochazka, K; Greinix, H; Haybaeck, J; Prokesch, A; Beham-Schmid, C; Feichtinger, J; Neumeister, P; Deutsch, A
Nr4a1 is implicated in the regulation of immune checkpoints in aggressive lymphomas
ONCOL RES TREAT. 2019; 42: 135-135.
[Oral Communication]
Web of Science
** Spindelbock, W; Huber-Krassnitzer, B; Uhl, B; Gorkiewicz, G; Greinix, H; Hogenauer, C; Neumeister, P
Treatment of acute refractory gastrointestinal graft-versus-host-disease by fecal microbiota transplantation
BONE MARROW TRANSPL. 2019; 54: 294-295.-45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT); MAR 24-27, 2019; Frankfurt, GERMANY.
[Poster]
Web of Science
** Uhl, B; Prochazka, K; Wenzl, K; Hatzl, S; Greinix, HT; Beham-Schmid, C; Neumeister, P; Deutsch, A
Differences of the chemokine receptor expression profile of aggressive lymphoma and GCB-cells and probable influence on clinical outcome
ONCOL RES TREAT. 2019; 42: 83-83.
[Poster]
Web of Science
** Fechter, K; Feichtinger, J; Prochazka, K; Unterluggauer, JJ; Pansy, K; Steinbauer, E; Pichler, M; Haybaeck, J; Prokesch, A; Greinix, HT; Beham-Schmid, C; Neumeister, P; Thallinger, GG; Deutsch, AJA
Cytoplasmic location of NR4A1 in aggressive lymphomas is associated with a favourable cancer specific survival.
Sci Rep. 2018; 8(1):14528-14528
Doi: 10.1038/s41598-018-32972-4
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Heldt, S; Prattes, J; Eigl, S; Spiess, B; Flick, H; Rabensteiner, J; Johnson, G; Prüller, F; Wölfler, A; Niedrist, T; Boch, T; Neumeister, P; Strohmaier, H; Krause, R; Buchheidt, D; Hoenigl, M
Diagnosis of invasive aspergillosis in hematological malignancy patients: Performance of cytokines, Asp LFD, and Aspergillus PCR in same day blood and bronchoalveolar lavage samples.
J Infect. 2018; 77(3):235-241
Doi: 10.1016/j.jinf.2018.05.001
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Hoenigl, M; Prattes, J; Neumeister, P; Wölfler, A; Krause, R
Real-world challenges and unmet needs in the diagnosis and treatment of suspected invasive pulmonary aspergillosis in patients with haematological diseases: An illustrative case study.
Mycoses. 2018; 61(3):201-205
Doi: 10.1111/myc.12727
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Prochazka, KT; Posch, F; Deutsch, A; Beham-Schmid, C; Stöger, H; Abdyli, L; Greinix, H; Pichler, M; Neumeister, P
Immunohistochemical double hit score enhances NCCN-IPI and is associated with detrimental outcomes in refractory or relapsing patients with diffuse large B cell lymphoma.
Br J Haematol. 2018; 183(1):142-146
Doi: 10.1111/bjh.14912
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Unterluggauer, JJ; Prochazka, K; Tomazic, PV; Huber, HJ; Seeboeck, R; Fechter, K; Steinbauer, E; Gruber, V; Feichtinger, J; Pichler, M; Weniger, MA; Küppers, R; Sill, H; Schicho, R; Neumeister, P; Beham-Schmid, C; Deutsch, AJA; Haybaeck, J
Expression profile of translation initiation factor eIF2B5 in diffuse large B-cell lymphoma and its correlation to clinical outcome.
Blood Cancer J. 2018; 8(9): 79-79.
Doi: 10.1038/s41408-018-0112-5
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Bergmann, TC; Pursche, B; Greinix, H; Neumeister, P; Deutsch, A; Prochazka, K
Overexpression of miR199a and miR497 regulates Nf-kappa B and B-cell receptor signalling in diffuse large B-cell lymphoma (DLBCL)
ONCOL RES TREAT. 2018; 41: 81-82.
[Poster]
Web of Science
** Brauchart, T; Bergmann, TC; Pansy, K; Fechter, K; Greinix, H; Neumeister, P; Deutsch, A
Starvation increases the anticancer activity of Ibrutinib in ABC-DLBCL cells in vitro
ONCOL RES TREAT. 2018; 41: 81-81.-DGHO; Oktober 2018; wien.
[Poster]
Web of Science
** Deutsch, A; Bergmann, TC; Fechter, K; Prochazka, K; Weniger, MA; Kuppers, R; Unterluggauer, JJ; Greinix, H; Beham-Schmid, C; Neumeister, P
Low NR4A1 expression is associated with an up-regulation of immune checkpoints and their ligands in DLBCL
ONCOL RES TREAT. 2018; 41: 82-82.
[Poster]
Web of Science
** Fechter, K; Feichtinger, J; Prochazka, K; Unterluggauer, JJ; Pansy, K; Pichler, M; Haybaeck, J; Prokesch, A; Greinix, H; Beham-Schmid, C; Neumeister, P; Thallinger, GG; Deutsch, A
Cytoplasmic location of NR4A1 in aggressive lymphomas is associated with a favorable cancer specific survival
ONCOL RES TREAT. 2018; 41: 82-83.
[Poster]
Web of Science
** Fechter, K; Pansy, K; Hauer, A; Kargl, J; Krogsdam, A; Greinix, H; Beham-Schmid, C; Neumeister, P; Prokesch, A; Deutsch, A
Nr4a1 has as a tumor suppressive function in Myc-driven lymphomagenesis by altering the tumor microenvironment
ONCOL RES TREAT. 2018; 41: 82-82.-DHGO; Oktober 2018; Wien.
[Poster]
Web of Science
** Heldt, S; Prattes, J; Eigl, S; Spiess, B; Flick, H; Rabensteiner, J; Johnson, G; Pruller, F; Wolfler, A; Niedrist, T; Boch, T; Neumeister, P; Strohmaier, H; Krause, R; Buchheidt, D; Hoenigl, M
Invasive Aspergillosis: Performance of New and Established Diagnostic Approaches with Same-Day Blood and Bronchoalveolar Lavage - a Prospective Cohort Study
MED MYCOL. 2018; 56: S34-S34.
[Poster]
Web of Science
** Neumeister, P
Treatment standards in aggressive lymphomas
ONCOL RES TREAT. . 2018; 41: 22-22.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie; SEP 28-OCT 2, 2018; Vienna, AUSTRIA.
[Oral Communication]
Web of Science
** Panny, M; Prochazka, K; Neumeister, P; Nosslinger, T; Rathkolb, V; Holzer, K; Bohm, A; Keil, F
Treatment of high risk aggressive B cell lymphomas with DA EPOCH R- the Austrian experience
ONCOL RES TREAT. 2018; 41: 46-46.
[Poster]
Web of Science
** Pansy, K; Fechter, K; Unterluggauer, JJ; Weniger, MA; Kuppers, R; Greinix, H; Prochazka, K; Karbiener, M; Neumeister, P; Deutsch, A
Reduced NR4A1 levels are associated with high expression of miR-15a and miR-15a*in DLBCL
ONCOL RES TREAT. 2018; 41: 81-81.
[Poster]
Web of Science
** Schukoff, T; Winkler, S; Unterluggauer, JJ; Fechter, K; Greinix, H; Beham-Schmid, C; Schaider, H; Deutsch, A; Prochazka, K; Neumeister, P
Distinct expression profiles of chemokine- and nuclear orphan receptors in the development and early progression of follicular lymphoma
ONCOL RES TREAT. 2018; 41: 50-50.
[Poster]
Web of Science
** Unterluggauer, JJ; Prochazka, K; Tomazic, PV; Huber, HJ; Seeboeck, R; Fechter, K; Steinbauer, E; Gruber, V; Feichtinger, J; Pichler, M; Weniger, MA; Kuppers, R; Sill, H; Schicho, R; Neumeister, P; Beham-Schmid, C; Deutsch, A; Haybaeck, J
Translation initiation factors are over-expressed in aggressive lymphomas and influence their clinical course
ONCOL RES TREAT. 2018; 41: 164-164.
[Poster]
Web of Science
** Deutsch, AJA; Rinner, B; Pichler, M; Prochazka, K; Pansy, K; Bischof, M; Fechter, K; Hatzl, S; Feichtinger, J; Wenzl, K; Frisch, MT; Stiegelbauer, V; Prokesch, A; Krogsdam, A; Sill, H; Thallinger, GG; Greinix, HT; Wang, C; Beham-Schmid, C; Neumeister, P
NR4A3 Suppresses Lymphomagenesis through Induction of Proapoptotic Genes.
Cancer Res. 2017; 77(9):2375-2386
Doi: 10.1158/0008-5472.CAN-16-2320
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Eigl, S; Hoenigl, M; Spiess, B; Heldt, S; Prattes, J; Neumeister, P; Wolfler, A; Rabensteiner, J; Prueller, F; Krause, R; Reinwald, M; Flick, H; Buchheidt, D; Boch, T
Galactomannan testing and Aspergillus PCR in same-day bronchoalveolar lavage and blood samples for diagnosis of invasive aspergillosis.
Med Mycol. 2017; 55(5):528-534
Doi: 10.1093/mmy/myw102
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Heldt, S; Eigl, S; Prattes, J; Flick, H; Rabensteiner, J; Prüller, F; Niedrist, T; Neumeister, P; Wölfler, A; Strohmaier, H; Krause, R; Hoenigl, M
Levels of interleukin (IL)-6 and IL-8 are elevated in serum and bronchoalveolar lavage fluid of haematological patients with invasive pulmonary aspergillosis.
Mycoses. 2017; 60(12):818-825
Doi: 10.1111/myc.12679
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Magina, KN; Pregartner, G; Zebisch, A; Wölfler, A; Neumeister, P; Greinix, HT; Berghold, A; Sill, H
Cytarabine dose in the consolidation treatment of AML: a systematic review and meta-analysis.
Blood. 2017; 130(7): 946-948.
Doi: 10.1182/blood-2017-04-777722
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Stauber, MN; Aberer, F; Oulhaj, A; Mader, JK; Zebisch, A; Pieber, TR; Neumeister, P; Greinix, HT; Sill, H; Sourij, H; Wölfler, A
Early Hyperglycemia after Initiation of Glucocorticoid Therapy Predicts Adverse Outcome in Patients with Acute Graft-versus-Host Disease.
Biol Blood Marrow Transplant. 2017; 23(7):1186-1192
Doi: 10.1016/j.bbmt.2017.03.010
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Kiesewetter, B; Willenbacher, E; Willenbacher, W; Egle, A; Neumeister, P; Voskova, D; Mayerhoefer, ME; Simonitsch-Klupp, I; Melchardt, T; Greil, R; Raderer, M; AGMT Investigators
A phase 2 study of rituximab plus lenalidomide for mucosa-associated lymphoid tissue lymphoma.
Blood. 2017; 129(3): 383-385.
Doi: 10.1182/blood-2016-06-720599
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Spindelboeck, W; Schulz, E; Uhl, B; Kashofer, K; Aigelsreiter, A; Zinke-Cerwenka, W; Mulabecirovic, A; Kump, PK; Halwachs, B; Gorkiewicz, G; Sill, H; Greinix, H; Högenauer, C; Neumeister, P
Repeated fecal microbiota transplantations attenuate diarrhea and lead to sustained changes in the fecal microbiota in acute, refractory gastrointestinal graft-versus-host-disease.
Haematologica. 2017; 102(5):e210-e213-e210-e213
Doi: 10.3324/haematol.2016.154351
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Deutsch, A; Pursche, B; Ehall, B; Zoidl, M; Fechter, K; Steinbauer, E; Sedej, M; Greinix, H; Prochazka, K; Wrodnigg, T; Beham-Schmid, C; Neumeister, P;
CXCR4 AND CXCL12 ARE IMPLICATED IN BONE MARROW INFILTRATION PROCESS OF AGGRESSIVE B CELL LYMPHOMAS AND THEIR INHIBITION SUPPRESSES LYMPHOMA CELL GROWTH IN VITRO.
HAEMATOLOGICA. HAEMATOLOGICA102: 572-572. PAVIA: FERRATA STORTI FOUNDATION; ( Presented at: 22nd Congress of the European-Hematology-Association, Madrid, SPAIN, JUN 22-25, 2017)
Web of Science
** Fechter, K; Wenzl, K; Prochazka, K; Pansy, K; Pursche, B; Greinix, H; Beham-Schmid, C; Neumeister, P; Deutsch, A
LOSS OF NR4A1 ACCELERATES MYC-DRIVEN LYMPHOMAGENESIS ACCOMPANIED BY OVEREXPRESSION OF GENES INVOLVED IN IMMUNOREGULATION.
HAEMATOLOGICA. 2017; 102: 560-561.-22nd Congress of the European-Hematology-Association; JUN 22-25, 2017; Madrid, SPAIN.
[Oral Communication]
Web of Science
** Fechter, K; Wenzl, K; Prochazka, K; Pansy, K; Pursche, B; Greinix, H; Beham-Schmid, C; Neumeister, P; Deutsch, A
Loss of Nr4a1 accelerates Myc-driven lymphomagenesis and alters the composition of immune cells in the tumor microenvironment
ONCOL RES TREAT. 2017; 40: 108-108.
[Poster]
Web of Science
** Heldt, S; Eigl, S; Prattes, J; Flick, H; Rabensteiner, J; Prueller, F; Niedrist, T; Neumeister, P; Obersteiner, S; Ober, J; Wolfler, A; Krause, R; Strohmaier, H; Hoenigl, M
Levels of interleukin-6 and-8 in serum and bronchoalveolar lavage fluid are elevated in haematological malignancy patients with invasive pulmonary aspergillosis: A nested case control study
MYCOSES. 2017; 60: 101-102.-TIMM; OCT 6-9, 2017; Belgrade, SERBIA.
[Poster]
Web of Science
** Heldt, S; Eigl, S; Prattes, J; Rabensteiner, J; Flick, H; Neumeister, P; Niedrist, T; Ober, J; Obersteiner, S; Prueller, F; Strohmaier, H; Krause, R; Wolfler, A; Hoenigl, M;
Levels of interleukin-6 and-8 in bronchoalveolar lavage fluid are elevated in haematological patients with invasive pulmonary aspergillosis: A case control study.
MYCOSES. . 2017; 60: 6-7.-51. wiss. Tagung der deutsschrachigen Mykologischen Gesellschaft; AUG 21 - SEPT 2, 2017; Münster.
[Oral Communication]
Web of Science
** Neumeister, P; Spindelboeck, W; Zinke-Cerwenka, W; Schulz, E; Hoegenauer, C; Sill, H; Gorkiewicz, G; Kump, P; Greinix, H
Successful treatment of steroid-refractory acute gastrointestinal graft-versus-host-disease by fecal microbiota transplantation
BONE MARROW TRANSPL. 2017; 52: S232-S232.
Web of Science
** Panny, M; Prochazka, K; Holzer, K; Neumeister, P; Nosslinger, T; Rathkolb, V; Greinix, H; Keil, F
Treatment of high risk aggressive B cell lymphomas with DA EPOCH R - a retrospective analysis
ONCOL RES TREAT. 2017; 40: 69-70.
[Poster]
Web of Science
** Stauber, M; Aberer, F; Oulhaj, A; Mader, JK; Zebisch, A; Pieber, TR; Neumeister, P; Greinix, HT; Sill, H; Sourij, H; Wolfler, A
Early hyperglycaemia after initiation of glucocorticoid therapy predicts adverse outcome in patients with acute graft-versus-host disease
BONE MARROW TRANSPL. 2017; 52: S285-S285.
Web of Science
** Unterluggauer, J; Beham-Schmid, C; Tomazic, PV; Fechter, K; Rinner, B; Pichler, M; Weniger, M; Kuppers, R; Sill, H; Schicho, R; Neumeister, P; Deutsch, A; Haybaeck, J
Translation initiation factors as novel prognostic biomarkers of aggressive B-cell lymphomas
VIRCHOWS ARCH. 2017; 471: S43-S43.
[Poster]
Web of Science
** Klamroth, R; Simpson, M; von Depka-Prondzinski, M; Gill, JC; Morfini, M; Powell, JS; Santagostino, E; Davis, J; Huth-Kühne, A; Leissinger, C; Neumeister, P; Bensen-Kennedy, D; Feussner, A; Limsakun, T; Zhou, M; Veldman, A; St Ledger, K; Blackman, N; Pabinger, I
Comparative pharmacokinetics of rVIII-SingleChain and octocog alfa (Advate(®) ) in patients with severe haemophilia A.
Haemophilia. 2016; 22(5):730-738
Doi: 10.1111/hae.12985
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Prochazka, KT; Melchardt, T; Posch, F; Schlick, K; Deutsch, A; Beham-Schmid, C; Weiss, L; Gary, T; Neureiter, D; Klieser, E; Greil, R; Neumeister, P; Egle, A; Pichler, M
NCCN-IPI score-independent prognostic potential of pretreatment uric acid levels for clinical outcome of diffuse large B-cell lymphoma patients.
Br J Cancer. 2016; 115(10):1264-1272
Doi: 10.1038/bjc.2016.325
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Troppan, KT; Melchardt, T; Wenzl, K; Schlick, K; Deutsch, A; Bullock, MD; Reitz, D; Beham-Schmid, C; Weiss, L; Neureiter, D; Tränkenschuh, W; Greil, R; Neumeister, P; Egle, A; Pichler, M
The clinical significance of fibrinogen plasma levels in patients with diffuse large B cell lymphoma.
J Clin Pathol. 2016; 69(4):326-330
Doi: 10.1136/jclinpath-2015-203356
Web of Science
PubMed
FullText
FullText_MUG
** Wenzl, K; Hofer, S; Troppan, K; Lassnig, M; Steinbauer, E; Wiltgen, M; Zulus, B; Renner, W; Beham-Schmid, C; Neumeister, P; Deutsch, A
Higher incidence of the SNP Met 788 Ile in the coding region of A20 in diffuse large B cell lymphomas.
Tumour Biol. 2016; 37(4):4785-4789
Doi: 10.1007/s13277-015-4322-1
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Deutsch, AJA; Rinner, B; Pichler, M; Fechter, K; Greinix, HT; Wang, CG; Beham-Schmid, C; Neumeister, P;
NR4A3 Suppresses Lymphomagenesis In Vitro and In Vivo by Induction of Similar Patterns of Pro-Apoptotic Genes like NR4A1.
BLOOD. BLOOD128: WASHINGTON: AMER SOC HEMATOLOGY; ( Presented at: 58th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), San Diego, CA, DEC 03-06, 2016)
Doi: 10.1182/blood.V128.22.2728.2728
Web of Science
FullText
FullText_MUG
** Panny, M; Troppan, K; Neumeister, P; Nosslinger, T; Holzer, K; Greinix, H; Keil, F
TREATMENT OF HIGH RISK AGGRESSIVE B CELL LYMPHOMAS WITH DA EPOCH R- A RETROSPECTIVE ANALYSIS
HAEMATOLOGICA. 2016; 101: 698-698.-21st Congress of the European-Hematology-Association; JUN 09-12, 2016; Copenhagen, DENMARK.
[Poster]
Web of Science
** Troppan, K; Beham, C; Greinix, H; Deutsch, A; Neumeister, P;
DOUBLE PROTEIN LYMPHOMA PATIENTS OF THE NON-GCB SUBTYPE HAVE AN INFERIOR PROGNOSIS WHEN TREATED WITH CHEMOIMMUNOTHERAPY.
HAEMATOLOGICA. HAEMATOLOGICA101: 396-397. PAVIA: FERRATA STORTI FOUNDATION; ( Presented at: 21st Congress of the European-Hematology-Association, Copenhagen, DENMARK, JUN 09-12, 2016)
Web of Science
** Troppan, K; Pregartner, G; Zach, V; Greinix, H; Neumeister, P
Identification of prognostic factors in patients with mature lymphoid malignancies undergoing autologous stem cell transplantation-a single center experience
BONE MARROW TRANSPL. 2016; 51: S506-S506.-42nd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation; APR 03-06, 2016; Valencia, SPAIN.
[Poster]
Web of Science
** Eigl, S; Prattes, J; Lackner, M; Willinger, B; Spiess, B; Reinwald, M; Selitsch, B; Meilinger, M; Neumeister, P; Reischies, F; Wölfler, A; Raggam, RB; Flick, H; Eschertzhuber, S; Krause, R; Buchheidt, D; Thornton, CR; Lass-Flörl, C; Hoenigl, M
Multicenter evaluation of a lateral-flow device test for diagnosing invasive pulmonary aspergillosis in ICU patients.
Crit Care. 2015; 19(5):178-178
Doi: 10.1186/s13054-015-0905-x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Eigl, S; Prattes, J; Reinwald, M; Thornton, CR; Reischies, F; Spiess, B; Neumeister, P; Zollner-Schwetz, I; Raggam, RB; Flick, H; Buchheidt, D; Krause, R; Hoenigl, M
Influence of mould-active antifungal treatment on the performance of the Aspergillus-specific bronchoalveolar lavage fluid lateral-flow device test.
Int J Antimicrob Agents. 2015; 46(4):401-405
Doi: 10.1016/j.ijantimicag.2015.05.017
Web of Science
PubMed
FullText
FullText_MUG
** Kepa, S; Horvath, B; Reitter-Pfoertner, S; Schemper, M; Quehenberger, P; Grundbichler, M; Heistinger, M; Neumeister, P; Mannhalter, C; Pabinger, I
Parameters influencing FVIII pharmacokinetics in patients with severe and moderate haemophilia A.
Haemophilia. 2015; 21(3):343-350
Doi: 10.1111/hae.12592
Web of Science
PubMed
FullText
FullText_MUG
** Lin, AP; Abbas, S; Kim, SW; Ortega, M; Bouamar, H; Escobedo, Y; Varadarajan, P; Qin, Y; Sudderth, J; Schulz, E; Deutsch, A; Mohan, S; Ulz, P; Neumeister, P; Rakheja, D; Gao, X; Hinck, A; Weintraub, ST; DeBerardinis, RJ; Sill, H; Dahia, PL; Aguiar, RC
D2HGDH regulates alpha-ketoglutarate levels and dioxygenase function by modulating IDH2.
Nat Commun. 2015; 6(7):7768-7768
Doi: 10.1038/ncomms8768
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Melchardt, T; Troppan, K; Weiss, L; Hufnagl, C; Neureiter, D; Tränkenschuh, W; Hopfinger, G; Magnes, T; Deutsch, A; Neumeister, P; Hackl, H; Greil, R; Pichler, M; Egle, A
A modified scoring of the NCCN-IPI is more accurate in the elderly and is improved by albumin and β2 -microglobulin.
Br J Haematol. 2015; 168(2):239-245
Doi: 10.1111/bjh.13116
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Melchardt, T; Troppan, K; Weiss, L; Hufnagl, C; Neureiter, D; Tränkenschuh, W; Schlick, K; Huemer, F; Deutsch, A; Neumeister, P; Greil, R; Pichler, M; Egle, A
Independent Prognostic Value of Serum Markers in Diffuse Large B-Cell Lymphoma in the Era of the NCCN-IPI.
J Natl Compr Canc Netw. 2015; 13(12):1501-1508
Doi: 10.6004/jnccn.2015.0178
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Prattes, J; Lackner, M; Eigl, S; Reischies, F; Raggam, RB; Koidl, C; Flick, H; Wurm, R; Palfner, M; Wölfler, A; Neumeister, P; Thornton, CR; Krause, R; Lass-Flörl, C; Hoenigl, M
Diagnostic accuracy of the Aspergillus-specific bronchoalveolar lavage lateral-flow assay in haematological malignancy patients.
Mycoses. 2015; 58(8):461-469
Doi: 10.1111/myc.12343
Web of Science
PubMed
FullText
FullText_MUG
** Rabensteiner, J; Theiler, G; Duettmann, W; Zollner-Schwetz, I; Hoenigl, M; Valentin, T; Leitner, E; Luxner, J; Grisold, A; Valentin, A; Neumeister, P; Krause, R
Detection of central venous catheter-related bloodstream infections in haematooncological patients.
Eur J Clin Invest. 2015; 45(8):824-832
Doi: 10.1111/eci.12477
Web of Science
PubMed
FullText
FullText_MUG
** Tiede, A; Klamroth, R; Scharf, RE; Trappe, RU; Holstein, K; Huth-Kühne, A; Gottstein, S; Geisen, U; Schenk, J; Scholz, U; Schilling, K; Neumeister, P; Miesbach, W; Manner, D; Greil, R; von Auer, C; Krause, M; Leimkühler, K; Kalus, U; Blumtritt, JM; Werwitzke, S; Budde, E; Koch, A; Knöbl, P
Prognostic factors for remission of and survival in acquired hemophilia A (AHA): results from the GTH-AH 01/2010 study.
BLOOD. 2015; 125(7): 1091-1097.
Doi: 10.1182/blood-2014-07-587089
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Troppan, K; Hofer, S; Wenzl, K; Lassnig, M; Pursche, B; Steinbauer, E; Wiltgen, M; Zulus, B; Renner, W; Beham-Schmid, C; Deutsch, A; Neumeister, P
Frequent down regulation of the tumor suppressor gene a20 in multiple myeloma.
PLoS One. 2015; 10(4):e0123922-e0123922
Doi: 10.1371/journal.pone.0123922
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Troppan, K; Wenzl, K; Pichler, M; Pursche, B; Schwarzenbacher, D; Feichtinger, J; Thallinger, GG; Beham-Schmid, C; Neumeister, P; Deutsch, A
miR-199a and miR-497 Are Associated with Better Overall Survival due to Increased Chemosensitivity in Diffuse Large B-Cell Lymphoma Patients.
Int J Mol Sci. 2015; 16(8):18077-18095
Doi: 10.3390/ijms160818077
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Troppan, KT; Melchardt, T; Deutsch, A; Schlick, K; Stojakovic, T; Bullock, MD; Reitz, D; Beham-Schmid, C; Weiss, L; Neureiter, D; Wenzl, K; Greil, R; Neumeister, P; Egle, A; Pichler, M
The significance of pretreatment anemia in the era of R-IPI and NCCN-IPI prognostic risk assessment tools: a dual-center study in diffuse large B-cell lymphoma patients.
Eur J Haematol. 2015; 95(6):538-544
Doi: 10.1111/ejh.12529
Web of Science
PubMed
FullText
FullText_MUG
** Neumeister, P; Troppan, K; Raderer, M
Management of gastric mucosa-associated lymphoid tissue lymphoma.
Dig Dis. 2015; 33(1):11-18
Doi: 10.1159/000366030
Web of Science
PubMed
FullText
FullText_MUG
** Troppan, K; Wenzl, K; Neumeister, P; Deutsch, A
Molecular Pathogenesis of MALT Lymphoma.
Gastroenterol Res Pract. 2015; 2015(9):102656-102656
Doi: 10.1155/2015/102656
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Wenzl, K; Troppan, K; Neumeister, P; Deutsch, AJ
The nuclear orphan receptor NR4A1 and NR4A3 as tumor suppressors in hematologic neoplasms.
Curr Drug Targets. 2015; 16(1):38-46
Doi: 10.2174/1389450115666141120112818
Web of Science
PubMed
FullText
FullText_MUG
** Fabian, E; Eisner, F; Pabinger, I; Viertler, C; Regauer, S; Lueger, A; Neumeister, P; Weiss, EC; Schöll, W; Lang, U; Prüller, F; Krejs, GJ
Clinical-Pathological Conference Series from the Medical University of Graz Case No 155: 26-year-old woman in third trimester of pregnancy with epigastric pain and thrombocytopenia.
Wien Klin Wochenschr. 2015; 127(17-18):707-714
Doi: 10.1007/s00508-015-0829-0
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
** Deutsch, A; Rinner, B; Wenzl, K; Troppan, K; Pursche, B; Beham-Schmid, C; Neumeister, P
NR4A1 AND NR4A3 POSSESS FUNCTIONAL REDUNDANCY BY REGULATING PRO-APOPTOTIC GENES IN AGGRESSIVE LYMPHOMAS.
HAEMATOLOGICA. 2015; 100: 544-544.-20th Congress of European-Hematology-Association; JUN 11-14, 2015; Vienna, AUSTRIA.
[Poster]
Web of Science
** Deutsch, AJA; Rinner, B; Wenzl, K; Troppan, K; Pursche, B; Greinix, HT; Beham-Schmid, C; Neumeister, P
NR4A3 Possesses Tumor Suppressive Properties like NR4A1 By Regulating Pro-Apoptotic Genes in Aggressive Lymphomas and Serves As a Potential Drug Target for Lymphoma Therapy
BLOOD. 2015; 126(23):-57th Annual Meeting of the American-Society-of-Hematology; DEC 05-08, 2015; Orlando, FL.
[Poster]
Web of Science
** Eigl, S; Prattes, J; Reischies, FM; Raggam, RB; Spiess, B; Reinwald, M; Buchheidt, D; Thornton, CR; Krause, R; Flick, H; Neumeister, P; Hoenigl, M
Galactomannan Testing and Aspergillus PCR in same-day bronchoalveolar lavage and blood samples obtained from patients with hematological malignancies at risk for invasive mould infection
MYCOSES. 2015; 58: 157-157.-TIMM; OCT 9-13, 2015; Lissabon, Portugal.
[Poster]
Web of Science
** Eisner, F; Neumeister, P; Lueger, A; Weiss, C; Krejs, GJ
Pregancy-associated thrombotic thrombocytopenic purpura in a 26-year old primipara
MED KLIN-INTENSIVMED. 2015; 110(4):302-302.-47. Jahrestagung der DGIIN/ÖGIAIN; JUN 17-19, 2015; Koeln, GERMANY.
[Poster]
Web of Science
** Kiesewetter, B; Greil, R; Willenbacher, W; Neumeister, P; Fridrik, MA; Markus, R
AGMT MALT-2: A Phase II Study of Rituximab Plus Lenalidomide in Patients with Extranodal Marginal Zone B-Cell Lymphoma of the Mucosa-Associated Lymphoid Tissue (MALT lymphoma)
BLOOD. 2015; 126(23):-55th Annual Meeting and Exposition of the American-Society-of-Hematology; DEC 07-10, 2013; New Orleans, LA.
[Oral Communication]
Web of Science
** Stauber, M; Aberer, F; Zebisch, A; Neumeister, P; Greinix, HT; Sill, H; Sourij, H; Wolfler, A
Steroid-induced hyperglycemia adversely impacts outcome in graft-versus-host disease
ONCOL RES TREAT. 2015; 38: 129-129.
[Poster]
Web of Science
** Troopan, K; Wenzl, K; Pichler, M; Pursche, B; Schwarzenbacher, D; Feichtinger, J; Thallinger, G; Beham-Schmid, C; Neumeister, P; Deutsch, A
MiR-199a and miR-497 are associated with better overall survival due to increased chemosensitivity in aggressive non-Hodgkin's lymphoma patients
ONCOL RES TREAT. 2015; 38: 63-64.
[Poster]
Web of Science
** Troppan, K; Wenzl, K; Neumeister, P; Beham-Schmid, C; Przekopowitz, M; Greinix, HT; Schaider, H; Deutsch, AJA
The Chemokine Receptor Profile As Distinctive Criterion Between Normal B-Cell Subsets and As Potential Discriminative Marker to Identify the Cell of Origin in Patients with Chronic Lymphocytic Leukemia and Richter Syndrome
BLOOD. 2015; 126(23):-55th Annual Meeting and Exposition of the American-Society-of-Hematology; DEC 07-10, 2013; New Orleans, LA.
[Poster]
Web of Science
** Vilits, T; Huber-Krassnitzer, B; Zinke-Cerwenka, W; Neumeister, P; Quehenberger, F; Hoenigl, M; Sill, H; Woffler, A
Impact of linezolid on hematopoietic engraftment in patients after umbilical cord blood stem cell transplantation
BONE MARROW TRANSPL. 2015; 50: S192-S192.-41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation; MAR 22-25, 2015; Istanbul, TURKEY.
[Poster]
Web of Science
** Wenzl, K; Troppan, K; Pursche, B; Bischof, M; Beham-Schmid, C; Greinix, HT; Neumeister, P; Deutsch, AJA
Loss of NR4A1 Accelerates the Development of Aggressive Lymphomas in Myc Induced Cancerogenesis
BLOOD. 2015; 126(23):-57th Annual Meeting of the American-Society-of-Hematology; DEC 05-08, 2015; Orlando, FL.
[Poster]
Web of Science
** Deutsch, AJ; Rinner, B; Wenzl, K; Pichler, M; Troppan, K; Steinbauer, E; Schwarzenbacher, D; Reitter, S; Feichtinger, J; Tierling, S; Prokesch, A; Scheideler, M; Krogsdam, A; Thallinger, GG; Schaider, H; Beham-Schmid, C; Neumeister, P
NR4A1-mediated apoptosis suppresses lymphomagenesis and is associated with a favorable cancer-specific survival in patients with aggressive B-cell lymphomas.
Blood. 2014; 123(15):2367-2377
Doi: 10.1182/blood-2013-08-518878
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Robier, C; Neubauer, M; Quehenberger, F; Stettin, M; Neumeister, P
Assessment of the response to acetylsalicylic acid in patients with myeloproliferative neoplasms by whole blood assays: a comparison of the PFA-100 with multiple electrode aggregometry.
Platelets. 2014; 25(8):608-611
Doi: 10.3109/09537104.2013.852661
Web of Science
PubMed
FullText
FullText_MUG
** Troppan, K; Deutsch, A; Gerger, A; Stojakovic, T; Beham-Schmid, C; Wenzl, K; Neumeister, P; Pichler, M
The derived neutrophil to lymphocyte ratio is an independent prognostic factor in patients with diffuse large B-cell lymphoma.
Br J Cancer. 2014; 110(2):369-374
Doi: 10.1038/bjc.2013.763
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Troppan, KT; Schlick, K; Deutsch, A; Melchardt, T; Egle, A; Stojakovic, T; Beham-Schmid, C; Weiss, L; Neureiter, D; Wenzl, K; Greil, R; Neumeister, P; Pichler, M
C-reactive protein level is a prognostic indicator for survival and improves the predictive ability of the R-IPI score in diffuse large B-cell lymphoma patients.
Br J Cancer. 2014; 111(1):55-60
Doi: 10.1038/bjc.2014.277
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Valentin, A; Troppan, K; Pfeilstöcker, M; Nösslinger, T; Linkesch, W; Neumeister, P
Safety and tolerability of intrathecal liposomal cytarabine as central nervous system prophylaxis in patients with acute lymphoblastic leukemia.
Leuk Lymphoma. 2014; 55(8):1739-1742
Doi: 10.3109/10428194.2013.853765
Web of Science
PubMed
FullText
FullText_MUG
** Troppan, K; Wenzl, K; Deutsch, A; Ling, H; Neumeister, P; Pichler, M
MicroRNAs in diffuse large B-cell lymphoma: implications for pathogenesis, diagnosis, prognosis and therapy.
Anticancer Res. 2014; 34(2):557-564
Web of Science
PubMed
** Deutsch, A; Rinner, B; Wenzl, K; Troppan, K; Beham-Schmid, C; Neumeister, P
NR4A3-MEDIATED APOPTOSIS SUPPRESSES LYMPHOMAGENESIS IN A XENOGRAFT MOUSE MODEL
HAEMATOLOGICA. .. 2014; 99: 136-136.-19th Congress of the European-Hematology-Association; JUN 12-15, 2014; Milan, ITALY.
[Poster]
Web of Science
** Duttmann, W; Wolfler, A; Koidl, C; Wagner, J; Lackner, G; Raggam, R; Petricevic, B; Neumeister, P; Krause, R; Honigl, M
Comparision of Mannan/Anti-Mannan and 1,3-beta-D-Glucan Screening for Invasive Candida Infection in Patients with Hematologic Malignancies
MYCOSES. 2014; 57: 33-34.
[Poster]
Web of Science
** Eigl, S; Fischbach, L; Prattes, J; Duttmann, W; Koidl, C; Huber-Krassnitzer, B; Neumeister, P; Wagner, J; Wolfler, A; Krause, R; Hoenigl, M
Serum and Urine Galactomannan testing for screening in patients with hematological malignancies
MYCOSES. 2014; 57: 24-24.
[Oral Communication]
Web of Science
** Raderer, M; Kiesewetter, B; Willenbacher, W; Neumeister, P; Fridrik, M; Greil, R
A PHASE II STUDY OF RITUXIMAB PLUS LENALIDOMIDE IN PATIENTS WITH EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA OF THE MUCOSA-ASSOCIATED LYMPHOID TISSUE (MALT LYMPHOMA)
HAEMATOLOGICA. . 2014; 99: 226-226.-19th Congress of the European-Hematology-Association; JUN 12-15, 2014; Milan, ITALY.
[Poster]
Web of Science
** Troppan, K; Wenzl, K; Deutsch, A; Pichler, M; Graupp, M; Beham-Schmid, C; Neumeister, P
HIGH EXPRESSION OF MIRNA-199A_1 AND MIRNA-497_1 IS ASSOCIATED WITH BETTER OVERALL SURVIVAL IN AGGRESSIVE NON-HODGKIN'S LYMPHOMA
HAEMATOLOGICA. 2014; 99: 135-135.
[Poster]
Web of Science
** Troppan, KT; Wenzl, K; Pursche, B; Schaider, H; Beham-Schmid, C; Deutsch, A; Neumeister, P
Distinct chemokine receptor profiles in Richter's transformation compared to de-novo diffuse large B-cell lymphoma and germinal center B-cells
ONCOL RES TREAT. 2014; 37: 72-73.
[Poster]
Web of Science
** Wenzl, K; Troppan, K; Deutsch, A; Neumeister, P
ANALYSES OF NUCLEAR ORPHAN RECEPTOR EXPRESSION AND CYTOTOXICITY FOLLOWING ANTI-CD 20 MONOCLONAL ANTIBODY TREATMENT IN AGGRESSIVE NON-HODGKIN'S LYMPHOMAS
HAEMATOLOGICA. 2014; 99: 685-686.-19th Congress of the European-Hematology-Association; JUN 12-15, 2014; Milan, ITALY.
[Poster]
Web of Science
** Wenzl, K; Troppan, K; Pursche, B; Schaider, H; Beham-Schmid, C; Deutsch, A; Neumeister, P
Patients with aggressive B-cell lymphomas display distinct chemokine receptor profile and an association of low CCR7 expression and favorable cancer specific survival
ONCOL RES TREAT. 2014; 37: 73-73.
[Poster]
Web of Science
** Neumeister, P; Sill, H
Novel face of microRNA-155.
Blood. 2014; 123(1):5-7
Doi: 10.1182/blood-2013-11-534107
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Deutsch, AJ; Steinbauer, E; Hofmann, NA; Strunk, D; Gerlza, T; Beham-Schmid, C; Schaider, H; Neumeister, P
Chemokine receptors in gastric MALT lymphoma: loss of CXCR4 and upregulation of CXCR7 is associated with progression to diffuse large B-cell lymphoma.
Mod Pathol. 2013; 26(2):182-194
Doi: 10.1038/modpathol.2012.134
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Unteregger, M; Valentin, A; Zinke-Cerwenka, W; Troppan, K; Deutsch, A; Cerroni, L; Linkesch, W; Neumeister, P
Unrelated SCT induces long-term remission in patients with blastic plasmacytoid dendritic cell neoplasm.
Bone Marrow Transplant. 2013; 48(6):799-802
Doi: 10.1038/bmt.2012.242
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Wagner, J; Schilcher, G; Zollner-Schwetz, I; Hoenigl, M; Valentin, T; Ribitsch, W; Horina, J; Rosenkranz, AR; Grisold, A; Unteregger, M; Troppan, K; Valentin, A; Neumeister, P; Krause, R
Microbiological screening for earlier detection of central venous catheter-related bloodstream infections.
Eur J Clin Invest. 2013; 43(9):964-969
Doi: 10.1111/eci.12126
Web of Science
PubMed
FullText
FullText_MUG
** Hoenigl, M; Duettmann, W; Huber-Krassnitzer, B; Theiler, G; Raggam, RB; Prueller, F; Zebisch, A; Neumeister, P; Wagner, J; Seeber, K; Wolfler, A; Krause, R;
Impact of structured on-site patient education on low posaconazole plasma concentrations.
MYCOSES. 2013; 56: 47-47.-6th Trends in Medical Mycology; OCT 11-14, 2013; Kopenhagen, DENMARK.
[Oral Communication]
Web of Science
** Hoenigl, M; Duettmann, W; Wagner, J; Raggam, RB; Huber-Krassnitzer, B; Cerewena-Zinke, W; Prueller, F; Koidl, C; Wolfler, A; Valentin, T; Zollner-Schwetz, I; Seeber, K; Buzina, W; Neumeister, P; Krause, R;
Comparision of galactomannan and beta-D-glucan serum assays for diagnosis of invasive fungal infections in hematologic malignancy patients.
MYCOSES. 2013; 56: 71-72.-6th Trends in Medical Mycology; OCT 11-14, 2014; Kopenhagen, DENMARK.
[Poster]
Web of Science
** Hoenigl, M; Koidl, C; Duettmann, W; Huber-Krassnitzer, B; Waitzl, B; Neumeister, P; Posch, V; Seeber, K; Wagner, J; Sill, H; Wolfler, A; Krause, R;
Serum and urine galactomannan testing for screening in patients with hematological malignancies.
MYCOSES. 2013; 56: 85-85.-6th Trends in Medical Mycology; OCT 11-14, 2013; Kopenhagen, DENMARK.
Web of Science
** Kepa, S; Reitter-Pfoertner, SE; Horvath, B; Heistinger, M; Neumeister, P; Rosenlechner, S; Schuster, G; Petz, B; Mannhalter, C; Pabinger, I
Parameters influencing factor VIII half-life and recovery in patients with haemophilia A
J THROMB HAEMOST. .. 2013; 11: 356-356.
[Poster]
Web of Science
** Linkesch, W; Zinke-Cerwenka, W; Wolfler, A; Still, H; Neumeister, P
UCBT with low-dose ATG in adult patients
ONKOLOGIE. 2013; 36: 127-128.
[Poster]
Web of Science
** Wenzl, K; Troppan, K; Deutsch, AJA; Linkesch, W; Neumeister, P; Beham-Schmid, C;
Distinct Chemokine Receptor Profile In Chronic Lymphocytic Leukaemia and Richter Transformed Diffuse Large B Cell Lymphomas Compared To Germinal Center B Cells and De Novo Diffuse Large B Cell Lymphomas.
BLOOD. BLOOD122: WASHINGTON: AMER SOC HEMATOLOGY; ( Presented at: 55th Annual Meeting of the American-Society-of-Hematology, New Orleans, LA, DEC 07-10, 2013)
Doi: 10.1182/blood.V122.21.4852.4852
Web of Science
FullText
FullText_MUG
** Deutsch, AJ; Angerer, H; Fuchs, TE; Neumeister, P
The nuclear orphan receptors NR4A as therapeutic target in cancer therapy.
Anticancer Agents Med Chem. 2012; 12(9):1001-1014
Doi: 10.2174/187152012803529619
Web of Science
PubMed
FullText
FullText_MUG
** Schlick, K; Aigelsreiter, A; Pichler, M; Reitter, S; Neumeister, P; Hoefler, G; Beham-Schmid, C; Linkesch, W
Histiocytic sarcoma - targeted therapy: novel therapeutic options? A series of 4 cases.
Onkologie. 2012; 35(7-8):447-450
Doi: 10.1159/000340066
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
** Valentin, T; Neumeister, P; Pichler, M; Rohn, A; Koidl, C; Haas, D; Heiling, B; Asslaber, M; Zollner-Schwetz, I; Hoenigl, M; Salzer, HJ; Krause, R; Buzina, W
Disseminated Geosmithia argillacea infection in a patient with gastrointestinal GvHD.
Bone Marrow Transplant. 2012; 47(5): 734-736.
Doi: 10.1038/bmt.2011.149
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Deutsch, AJA; Pichler, M; Reitter, S; Troppan, K; Beham-Schmid, C; Neumeister, P;
Reduction of NR4A1 is associated with poor survival aggressive lymphomas.
ONKOLOGIE. 2012; 35: 104-104.-Gemeinsame Jahrestagung 2012 der DGHO, ÖGHO, SGMO und SGH+SSH ; Okt 19-23, 2012; Stuttgart.
[Oral Communication]
Web of Science
** Deutsch, AJA; Rinner, B; Pichler, M; Reitter, S; Beham-Schmid, C; Neumeister, P;
NR4A1 Mediated Apoptosis of Aggressive Lymphoma Cells Suppresses Tumor Growth in a Xenograft Model.
BLOOD. . 2012; 120(21):-54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH); DEC 08-11, 2012; Atlanta, GA.
Doi: 10.1182/blood.V120.21.2408.2408
[Poster]
Web of Science
FullText
FullText_MUG
** Valentin, A; Unteregger, M; Troppan, K; Zinke-Cerwenka, W; Cerroni, L; Linkesch, W; Neumeister, P;
Unrelated stem cell transplantation induces long term disease control in patients with blastic plasmocytoid dendritic cell neoplasm.
ONKOLOGIE. 2012; 35: 212-213.-Jahrestagung der DÖGHO; OKT 19-23. 2012; Stuttgart.
[Poster]
Web of Science
** Aigelsreiter, A; Gerlza, T; Deutsch, AJ; Leitner, E; Beham-Schmid, C; Beham, A; Popper, H; Borel, N; Pospischil, A; Raderer, M; Kessler, HH; Neumeister, P
Chlamydia psittaci Infection in nongastrointestinal extranodal MALT lymphomas and their precursor lesions.
Am J Clin Pathol. 2011; 135(1): 70-75.
Doi: 10.1309/AJCPXMDRT1SY6KIV
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Rohn, A; Kessler, HH; Valentin, T; Linkesch, W; Neumeister, P
Prophylactic oseltamivir treatment for prevention of donor-recipient influenza A H1N1 virus transmission does not compromise stem cell mobilization or engraftment.
Bone Marrow Transplant. 2011; 46(2): 312-313.
Doi: 10.1038/bmt.2010.97
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Schlick, K; Regauer, S; Beham-Schmid, C; Cerroni, L; Rohn, A; Deutsch, AJ; Linkesch, W; Neumeister, P; Aigelsreiter, A
Pyoderma gangrenosum heralding acute leukemia for months: diagnostic hint written on the skin.
J Clin Oncol. 2011; 29(17): e506-e508.
Doi: 10.1200/JCO.2010.34.3855
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Worel, N; Rosskopf, K; Neumeister, P; Kasparu, H; Nachbaur, D; Russ, G; Namberger, K; Witt, V; Schloegl, E; Zojer, N; Linkesch, W; Kalhs, P; Greinix, HT
Plerixafor and granulocyte-colony-stimulating factor (G-CSF) in patients with lymphoma and multiple myeloma previously failing mobilization with G-CSF with or without chemotherapy for autologous hematopoietic stem cell mobilization: the Austrian experience on a named patient program.
Transfusion. 2011; 51(5):968-975
Doi: 10.1111/j.1537-2995.2010.02896.x
Web of Science
PubMed
FullText
FullText_MUG
** Deutsch, AJA; Kessler, HH; Neumeister, P
Chlamydia psittaci Infection in Nongastrointestinal MALT Lymphomas and Their Precursor Lesions Reply
AM J CLIN PATHOL. 2011; 136(3): 481-481.
Doi: 10.1309/AJCPWRH1K8EFCUGX
Web of Science
FullText
FullText_MUG
** Schlick, K; Schilcher, G; Krisper, P; Neumeister, P; Linkesch, W; Beham-Schmid, C; Aigelsreiter, A
Spontaneous Tumor Lysis Syndrome Presenting As Acute Renal Failure in an Adult With De Novo Aleukemic T-ALL: Value of Renal Biopsy?
J CLIN ONCOL. 2011; 29(17): E494-E496.
Doi: 10.1200/JCO.2010.33.1504
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Buzina, W; Valentin, T; Neumeister, P
Geosmithia argillacea - an emerging pathogen in immunocompromised hosts - often overlooked as "Penicillium contamination"?
MYCOSES. 2011; 54(5):376-376.-45th Annual Meeting of the German-Speaking Mycological Society (DMykG); SEP 1-3, 2011; Kiel, GERMANY.
[Oral Communication]
Web of Science
** Deutsch, AJA; Rinner, B; Stradner, MH; Angerer, H; Linkesch, W; Beham-Schmid, C; Neumeister, P
Cytosporone B induces NR4A1 meditated apoptosis in aggressive lymphoma cells
ONKOLOGIE. 2011; 34: 72-72.
[Poster]
Web of Science
** Linkesch, W; Neumeister, P; Zinke-Cerwenka, W; Strunk, D; Sill, H
UCBT with low-dose ATG in adults
BONE MARROW TRANSPLANT. 2011; 46: S128-S129.
[Poster]
Web of Science
** Linkesch, W; Sill, H; Zinke-Cerwenka, W; Neumeister, P; Strunk, D
Results of UCBT with ATG in adults.
Onkologie. 2011; 34(6):271-271.-Jahrestagung der DÖuSGHO; SEP 30-OCT 04, 2011; Basel.
[Poster]
Web of Science
** Robier, C; Neubauer, M; Sternad, H; Quehenberger, F; Rainer, F; Neumeister, P
Evaluation of platelet function and pharmacological platelet inhibition in patients with myeloproliferative disorders using multiple electrode aggregometry.
THROMB RES. 2010; 126(3): 232-237.
Doi: 10.1016/j.thromres.2010.06.014
Web of Science
PubMed
FullText
FullText_MUG
** Reitter, S; Neumeister, P; Beham-Schmid, C; Emberger, W; Strunk, D; Brezinschek, R; Linkesch, W; Schmidt, HH
A case of generalized MALT lymphoma with IgM paraproteinemia and peripheral blood involvement.
Ann Hematol. 2010; 89(2): 213-214.
Doi: 10.1007/s00277-009-0787-6
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Deutsch, AJA; Rinner, B; Knausz, H; Linkesch, W; Beham-Schmid, C; Neumeister, P
Ccytosporone-B Induces NR4A1 Meditated Apoptosis In Aggressive Lymphoma Cells
BLOOD. 2010; 116(21): 208-209.
Web of Science
** Neumeister, P; Schmidt, H; Linkesch, W; Pfeilstocker, M; Rohn, A
SAFETY AND TOLERABILITY OF INTRATHECAL LIPOSOMAL CYTARABINE AS CNS PROPHYLAXIS IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
HAEMATOL-HEMATOL J. 2010; 95: 0621 -15th Congress of the European Hematology Association.; JUNE 10-13; Barcelona, SPAIN.
[Poster]
Web of Science
** Robier, C; Neubauer, M; Stemad, H; Rainer, F; Quehenberger, F; Neumeister, P
Evaluation of platelet function and pharmacological platelet inhibition in patients with myeloproliferative disorders by multiple electrode aggregometry
ONKOLOGIE. 2010; 33: 52-52.
[Poster]
Web of Science
** Zinke-Cerwenka, W; Stojakovic, T; Rohn, A; Ziegler, I; Emberger, W; Sipurzynski, S; Linkesch, W; Neumeister, P
First-line treatment with bortezomib, doxorubicine and dexamethasone followed by autologous peripheral blood stem cell transplantation in newly diagnosed patients with multiple myeloma
BONE MARROW TRANSPLANT. 2010; 45(2):S149-S149.-36th Annual Meeting of the European Group for Blood and Marrow Transplantation; MAR 21-24, 2010; Vienna, AUSTRIA.
[Poster]
Web of Science
** Deutsch, AJ; Frühwirth, M; Aigelsreiter, A; Cerroni, L; Neumeister, P
Primary cutaneous marginal zone B-cell lymphomas are targeted by aberrant somatic hypermutation.
J Invest Dermatol. 2009; 129(2): 476-479.
Doi: 10.1038/jid.2008.243
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Deutsch, AJA; Beham-Schmid, C; Linkesch, W; Neumeister, P
The Nuclear Orphan Receptors NR4A1 and NR4A3 as Putative Tumour Suppressor Genes in Aggressive Non-Hodgkin's Lymphomas.
Blood2009; 114(22):1158-1158.-51st ASH Annual Meeting of the American Society of Hematology ; Dec 5-8, 2009; New Orleans, LA.
[Poster]
Web of Science
** Valentin, T; Neumeister, P; Brezinschek, R; Buzina, W; Zollner-Schwetz I; Krause, R
Pulmonary, pleural and thoracic wall wound infection with Rhizopus oryzae
Wiener Klinische Wochenschrift2009; 121(17):A57--Jahrestagung der Österr. Gesellschaft für Pneumologie; Juni 11-13, 2009; Salzburg, AUSTRIA.
[Poster]
Web of Science
** Aigelsreiter, A; Leitner, E; Deutsch, AJ; Kessler, HH; Stelzl, E; Beham-Schmid, C; Beham, A; Krugmann, J; Dinges, HP; Linkesch, W; Neumeister, P
Chlamydia psittaci in MALT lymphomas of ocular adnexals: the Austrian experience.
Leuk Res. 2008; 32(8): 1292-1294.
Doi: 10.1016/j.leukres.2007.10.013
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Deutsch, A; Aigelsreiter, A; Steinbauer, E; Frühwirth, M; Kerl, H; Beham-Schmid, C; Schaider, H; Neumeister, P
Distinct signatures of B-cell homeostatic and activation-dependent chemokine receptors in the development and progression of extragastric MALT lymphomas.
J Pathol. 2008; 215(4): 431-444.
Doi: 10.1002/path.2372
Web of Science
PubMed
FullText
FullText_MUG
** Halldórsdóttir, AM; Frühwirth, M; Deutsch, A; Aigelsreiter, A; Beham-Schmid, C; Agnarsson, BA; Neumeister, P; Richard Burack, W
Quantifying the role of aberrant somatic hypermutation in transformation of follicular lymphoma.
Leuk Res. 2008; 32(7): 1015-1021.
Doi: 10.1016/j.leukres.2007.11.028
Web of Science
PubMed
FullText
FullText_MUG
** Langner, S; Staber, PB; Neumeister, P
Posaconazole in the management of refractory invasive fungal infections.
Ther Clin Risk Manag. 2008; 4(4): 747-758.
Doi: 10.2147/TCRM.S3329
[OPEN ACCESS]
PubMed
FullText
FullText_MUG
** Langner, S; Staber, PB; Schub, N; Gramatzki, M; Grothe, W; Behre, G; Rabitsch, W; Urban, C; Linkesch, W; Neumeister, P
Palifermin reduces incidence and severity of oral mucositis in allogeneic stem-cell transplant recipients.
Bone Marrow Transplant. 2008; 42(4): 275-279.
Doi: 10.1038/bmt.2008.157
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Jaeger, G; Bauer, F; Brezinschek, R; Beham-Schmid, C; Mannhalter, C; Neumeister, P
Hepatosplenic gammadelta T-cell lymphoma successfully treated with a combination of alemtuzumab and cladribine.
ANN ONCOL. 2008; 19(5): 1025-1026.
Doi: 10.1093/annonc/mdn119
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Deutsch, AJA; Brezinschek, RI; Brezinschek, HP; Beham-Schmid, C; Neumeister, P
Relapsed MALT Lymphomas Are Associated with a Restricted VH3-30.3 Immunoglobulin VH Gene Repertoire and Are Targeted by Aberrant Somatic Hypermutation.
BLOOD. 2008; 112(11):978-978.-50th Annual Meeting of the American- Society-of-Hematology; DEC 06-09, 2008; San Francisco, CA.
[Poster]
Web of Science
** Deutsch, AJ; Aigelsreiter, A; Staber, PB; Beham, A; Linkesch, W; Guelly, C; Brezinschek, RI; Fruhwirth, M; Emberger, W; Buettner, M; Beham-Schmid, C; Neumeister, P
MALT lymphoma and extranodal diffuse large B-cell lymphoma are targeted by aberrant somatic hypermutation.
Blood. 2007; 109(8):3500-3504
Doi: 10.1182/blood-2006-06-030494
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Jäger, G; Quehenberger, F; Linkesch, W; Neumeister, P
CHOP chemotherapy followed by Rituximab consolidation as first line treatment in patients with follicular lymphoma. Long-term follow-up of a phase 2 trial.
EUR J HAEMATOL. 2007; 78(5): 453-455.
Doi: 10.1111/j.1600-0609.2007.00848.x
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Staber, P; Langner, S; Dornbusch, HJ; Neumeister, P
Antifungal management in cancer patients.
Wien Med Wochenschr. 2007; 157(19-20):503-510
Doi: 10.1007/s10354-007-0466-y
PubMed
FullText
FullText_MUG
** Aigelsreiter, A; Deutsch, AJA; Stelzl, E; Beham-Schmid, C; Beham, A; Linkesch, W; Schaider, H; Kessler, HH; Neumeister, P
Different chemokine receptor expression profile in extragastric and gastric MALT-lymphomas
MODERN PATHOL. 2007; 20: 232A-232A.
[Poster]
Web of Science
** Aigelsreiter, A; Deutsch, AJA; Stelzl, E; Beham-Schmid, C; Beham, A; Linkesch, W; Schaider, H; Kessler, HH; Neumeister, P
Different chemokine receptor expression profile in extragastric and gastric MALT-lymphomas
LAB INVEST. 2007; 87: 232A-232A.
[Poster]
Web of Science
** Deutsch, AJA; Aigelsreiter, A; Steinbauer, E; Linkesch, W; Beham-Schmid, C; Schaider, H; Neumeister, P
Chemokine receptor expression profile in the model of parotid MALT lymphomagenesis: De novo expression of CXCR6.
BLOOD. 2007; 110(11):772A-772A.-49 th Annual Meeting of the American Society of Hematology; NOV 16, 2007; Atlanta, USA.
[Poster]
Web of Science
** Langner, S; Staber, P; Schub, N; Gramatzki, M; Grothe, W; Behre, G; Rabitsch, W; Linkesch, W; Neumeister, P
Palifermin in unrelated donor transplant recipients
HAEMATOL-HEMATOL J. 2007; 92: 172-173.
[Poster]
Web of Science
** Neumeister, PN; Pfeilstocker, M; Linkesch, W; Rohn, A
Safety and tolerability of intrathecal liposomal cytarabine as cns prophylaxis in patients with acute lymphoblastic leukemia
HAEMATOL-HEMATOL J. 2007; 92: 8-9.
[Poster]
Web of Science
** Jager, G; Neumeister, P; Quehenberger, F; Wohrer, S; Linkesch, W; Raderer, M
Prolonged clinical remission in patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type treated with cladribine: 6 year follow-up of a phase II trial.
ANN ONCOL. 2006; 17(11): 1722-1723.
Doi: 10.1093/annonc/mdl126
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Aigelsreiter, A; Stelzl, E; Deutsch, A; Beham-Schmid, C; Beham, A; Lanzer, G; Linkesch, W; Kessler, H; Neumeister, P
Association between Chlamydia psittaci infection and extranodal marginal zone B-cell lymphoma of mucosa associated lymphoid tissue (MALT)-lymphomas.
J CLIN ONCOL. 2006; 24(18):438S-438S.-ASCO; 2.-6. Juni 2006; Altlanta, USA.
[Poster]
Web of Science
** Fruehwirth, M; Deutsch, AJA; Staber, PB; Aigelsreiter, A; Linkesch, W; Beham-Schimid, C; Neumeister, P
Aberrant somatic hypermutation of follicular lymphoma transformed to diffuse large B-cell lymphoma.
BLOOD. 2006; 108(11): 683A-683A.
Doi: 10.1182/blood.V108.11.2413.2413
[Poster]
Web of Science
FullText
FullText_MUG
** Langner, S; Staber, P; Radspieler, G; Triebl-Roth, K; Urban, C; Zinke-Cerwenka, W; Sill, H; Linkesch, W; Neumeister, P
Palifermin reduces oral mucositis and enhances the recovery of intestinal mucosa measured by citrulline serum levels in allogeneic and autologous stem cell transplant recipients
BONE MARROW TRANSPLANT. 37: S73-S74.-32nd Annual Meeting of the European-Group-for-Blood-and-Morrow-Transplantation/22nd Meeting of the EBMT-Nures-Group/5th Meeting of the EMBT-Data-Management-Group; MAR 19-22, 2006; Hamburg, GERMANY.
[Poster]
Web of Science
** Langner, S; Staber, PB; Zebisch, A; Zinke-Cerwenka, W; Sill, H; Linkesch, W; Greinix, H; Kalhs, P; Rabitsch, W; Neumeister, P
Adding palifermin in allogeneic and autologous stem cell transplantation resulted in reduced oral mucositis and enhanced intestinal mucosal recovery measured by citrulline serum levels.
BLOOD. 2006; 108(11): 404B-404B.
Doi: 10.1182/blood.V108.11.5251.5251
[Poster]
Web of Science
FullText
FullText_MUG
** Zinke-Cerwenka, W; Eibl, M; Neumeister, P; Sill, H; Linkesch, W
Late effects after autologous peripheral blood stem cell transplantation followed by reduced-intensity allogeneic peripheral blood stem cell transplantation in patients with multiple myeloma
BONE MARROW TRANSPLANT. ; 37: S113-S113.-32nd Annual Meeting of the European-Group-for-Blood-and-Morrow-Transplantation/22nd Meeting of the EBMT-Nures-Group/5th Meeting of the EMBT-Data-Management-Group; MAR 19-22, 2006; Hamburg, GERMANY.
[Poster]
Web of Science
** Jaeger, G; Linkesch, W; Temmel, W; Neumeister, P
AntiCD20 monoclonal antibody-based radioimmunotherapy of relapsed chemoresistant aggressive post-transplantation B-lymphoproliferative disorder in heart-transplant recipient.
LANCET ONCOL. 2005; 6(8): 629-631.
Doi: 10.1016/S1470-2045(05)70286-2
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Macher, S; Schallmoser, K; Staber, PB; Neumeister, P; Posch, U; Lanzer, G; Panzer, S
Severe thrombocytopenia due to host-derived anti-HPA-1a after non-myeloablative allogeneic haematopoietic stem cell transplantation for multiple myeloma: a case report.
VOX SANG. 2005; 89(4): 257-260.
Doi: 10.1111/j.1423-0410.2005.00692.x
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
** Staber, PB; Holub, R; Linkesch, W; Schmidt, H; Neumeister, P
Fixed-dose single administration of Pegfilgrastim vs daily Filgrastim in patients with haematological malignancies undergoing autologous peripheral blood stem cell transplantation.
BONE MARROW TRANSPLANT. 2005; 35(9): 889-893.
Doi: 10.1038/sj.bmt.1704927
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Deutsch, A; Aigelsreiter, A; Beham-Schmid, C; Beham, A; Linkesch, W; Neumeister, P
Aberrant somatic hypermutation in extranodal marginal zone B-cell lymphoma of MALT type.
BLOOD. 2005; 106: 125A-126A.-47th Annual Meeting of the American-Society-of-Hematology; DEC 10-13, 2005; Atlanta, GA.
Web of Science
** Macher, S; Schallmoser, K; Staber, P; Neumeister, P; Rosskopf, K; Posch, U; Panzer, S; Lanzer, G
Severe immune thrombocytopenia due to HPA-1 a host-derived antibodies after non-myeloablative allogeneic hematopoetic stem cell transplantation for multiple myeloma
TRANSFUSION 2005 45: 114A-114A.
Web of Science
** Zinke-Cerwenka, W; Neumeister, P; Eibl, M; Sill, H; Emberger, W; Wagner, T; Wolfler, A; Linkesch, W
Planned sequential autologous/non-myeloablative allogeneic peripheral stem cell transplantation in patients with newly diagnosed high-risk multiple myeloma
BONE MARROW TRANSPLANT 2005 35: S387-S388.
Web of Science
** Jäger, G; Höfler, G; Linkesch, W; Neumeister, P
Occurrence of a myelodysplastic syndrome (MDS) during first-line 2-chloro-deoxyadenosine (2-CDA) treatment of a low-grade gastrointestinal MALT lymphoma. Case report and review of the literature.
Haematologica. 2004; 89(4): ECR01-ECR01.
(- Case Report)
[OPEN ACCESS]
PubMed
FullText
Google Scholar
** Eibl, M; Zinke-Cerwenka, W; Neumeister, P; Wolfler, A; Sill, H; Linkesch, W
Autologous stem cell transplantation for multiple myeloma in elderly patients
BONE MARROW TRANSPLANT 2004 33: S357-S357.
Web of Science
** Neumeister, P; Holub, R; Staber, PB; Linkesch, W
Pegfilgrastim shows safety and efficacy similar to filgrastim in patients undergoing autologous stem cell transplantation for hematological malignancies.
BLOOD 2004 104: 327A-327A.
Doi: 10.1182/blood.V104.11.1156.1156
Web of Science
FullText
FullText_MUG
** Neumeister, P; Pixley, FJ; Xiong, Y; Xie, H; Wu, K; Ashton, A; Cammer, M; Chan, A; Symons, M; Stanley, ER; Pestell, RG
Cyclin D1 governs adhesion and motility of macrophages.
Mol Biol Cell. 2003; 14(5):2005-2015
Doi: 10.1091/mbc.02-07-0102
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Staber, PB; Brezinschek, R; Linkesch, W; Sill, H; Neumeister, P
Durable molecular response to imatinib mesylate following nonmyeloablative allogeneic stem-cell transplantation for persisting myeloid blast crisis in chronic myeloid leukemia.
Haematologica. 2003; 88(8):ECR29-ECR29
(- Case Report)
[OPEN ACCESS]
PubMed
Google Scholar
** Wang, C; Pattabiraman, N; Zhou, JN; Fu, M; Sakamaki, T; Albanese, C; Li, Z; Wu, K; Hulit, J; Neumeister, P; Novikoff, PM; Brownlee, M; Scherer, PE; Jones, JG; Whitney, KD; Donehower, LA; Harris, EL; Rohan, T; Johns, DC; Pestell, RG
Cyclin D1 repression of peroxisome proliferator-activated receptor gamma expression and transactivation.
Mol Cell Biol. 2003; 23(17):6159-6173
Doi: 10.1128%2FMCB.23.17.6159-6173.2003
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Staber, PB; Neumeister, P; Duerkop, H; Schauer, S; Linkesch, W; Hoefler, G
CD30 induced cell death in anaplastic large cell lymphoma involves perforin/granzyme cell death pathway and the caspase dependent death receptors TNFR-1 and FAS/APO-1.
BLOOD 2003 102: 885A-885A.
Web of Science
** Holnthoner, W; Pillinger, M; Groger, M; Wolff, K; Ashton, AW; Albanese, C; Neumeister, P; Pestell, RG; Petzelbauer, P
Fibroblast growth factor-2 induces Lef/Tcf-dependent transcription in human endothelial cells.
J Biol Chem. 2002; 277(48):45847-45853
Doi: 10.1074/jbc.M209354200
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Jäeger, G; Neumeister, P; Brezinschek, R; Höfler, G; Quehenberger, F; Linkesch, W; Sill, H
Rituximab (anti-CD20 monoclonal antibody) as consolidation of first-line CHOP chemotherapy in patients with follicular lymphoma: a phase II study.
EUR J HAEMATOL 2002 69: 21-26.
Doi: 10.1034%2Fj.1600-0609.2002.01692.x
Web of Science
PubMed
FullText
FullText_MUG
** Jäger, G; Neumeister, P; Brezinschek, R; Hinterleitner, T; Fiebiger, W; Penz, M; Neumann, HJ; Mlineritsch, B; DeSantis, M; Quehenberger, F; Chott, A; Beham-Schmid, C; Höfler, G; Linkesch, W; Raderer, M
Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type with cladribine: a phase II study.
J Clin Oncol. 2002; 20(18):3872-3877
Doi: 10.1200/JCO.2002.05.117
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Neumeister, P; Albanese, C; Balent, B; Greally, J; Pestell, RG
Senescence and epigenetic dysregulation in cancer.
Int J Biochem Cell Biol. 2002; 34(11):1475-1490
Doi: 10.1016%2FS1357-2725%2802%2900079-1
Web of Science
PubMed
FullText
FullText_MUG
** Konstantinidis, A; Heiden, A; Stastny, J; Baecker, C; Letmaier, M; Winkler, D; Neumeister, A; Kasper, S
Rapid transcranial magnetic stimulation (r-TMS): A novel treatment option for seasonal affective disorder (SAD)?
EUR NEUROPSYCHOPHARMACOL. 2002; 12: S252-S252.
[Poster]
Web of Science
** Zinke-Cerwenka, W; Eibl, M; Beham-Schmid, C; Sormann, S; Neumeister, P; Linkesch, W
Autologous stem cell transplantation in patients with peripheral T-cell lymphomas
BONE MARROW TRANSPLANT. 2002; 29: S88-S88.
Web of Science
** Mitterbauer, M; Neumeister, P; Kalhs, P; Brugger, S; Fischer, G; Dieckmann, K; Hoecker, P; Hinterberger, W; Linkesch, W; Simonitsch, I; Jaeger, U; Lechner, K; Mannhalter, C; Mitterbauer, G; Greinix, HT
Long-term clinical and molecular remission after allogeneic stem cell transplantation (SCT) in patients with poor prognosis non-Hodgkin's lymphoma.
Leukemia. 2001; 15(4):635-641
Doi: 10.1038/sj.leu.2402053
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Neumeister, P; Eibl, M; Zinke-Cerwenka, W; Scarpatetti, M; Sill, H; Linkesch, W
Hepatic veno-occlusive disease in two patients with relapsed acute myeloid leukemia treated with anti-CD33 calicheamicin (CMA-676) immunoconjugate.
Ann Hematol. 2001; 80(2):119-120
Doi: 10.1007%2Fs002770000239
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Neumeister, P; Jaeger, G; Eibl, M; Sormann, S; Zinke, W; Linkesch, W
Amifostine in combination with erythropoietin and G-CSF promotes multilineage hematopoiesis in patients with myelodysplastic syndrome.
Leuk Lymphoma. 2001; 40(3-4):345-349
Doi: 10.3109/10428190109057933
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Pasqualucci, L; Neumeister, P; Goossens, T; Nanjangud, G; Chaganti, RS; Küppers, R; Dalla-Favera, R
Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas.
Nature. 2001; 412(6844):341-346
Doi: 10.1038/35085588
Web of Science
PubMed
FullText
FullText_MUG
** Zinke-Cerwenka, W; Eibl, M; Sormann, S; Neumeister, P; Linkesch, W
Comparison of central venous catheters versus implantable intravenous devices in patients undergoing stem cell transplantation
BONE MARROW TRANSPLANT. 2001; 27: S311-S311.
Web of Science
** Apfelbeck, U; Hoefler, G; Neumeister, P; Fonatsch, C; Linkesch, W; Sill, H
Extramedullary T cell lymphoblastic transformation of chronic myeloid leukaemia successfully treated with matched unrelated donor bone marrow transplantation.
BONE MARROW TRANSPLANT 2000 26: 1111-1112.
Doi: 10.1038/sj.bmt.1702665
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Chopra, R; Eaton, JD; Grassi, A; Potter, M; Shaw, B; Salat, C; Neumeister, P; Finazzi, G; Iacobelli, M; Bowyer, K; Prentice, HG; Barbui, T
Defibrotide for the treatment of hepatic veno-occlusive disease: results of the European compassionate-use study.
Br J Haematol. 2000; 111(4):1122-1129
Doi: 10.1046%2Fj.1365-2141.2000.02475.x
Web of Science
PubMed
FullText
FullText_MUG
** Neumeister, P; Hoefler, G; Beham-Schmid, C; Sill, H; Linkesch, W
Complete remission of generalized relapsed extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type of the gastrointestinal tract after high-dose chemotherapy and autologous peripheral stem cell transplantation.
ANN HEMATOL 2000 79: 703-705.
Doi: 10.1007%2Fs002770000203
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Neumeister, P; Strunk, D; Apfelbeck, U; Sill, H; Linkesch, W
Adoptive transfer of vitiligo after allogeneic bone marrow transplantation for non-Hodgkin's lymphoma.
Lancet. 2000; 355(9212):1334-1335
Doi: 10.1016/S0140-6736(00)02120-6
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Jager, G; Brezinschek, R; Neumeister, P; Linkesch, W
Consolidation with Rituximab(Mab-Thera (TM)) after CHOP-induction as first-line treatment of follicular lymphoma. A phase II study.
BLOOD 2000 96: 240B-240B.
Web of Science
** Neumeister, P; Zinke, W; Sill, H; Linkesch, W
Antithymocyte globulin may reduce chronic graft versus host disease in patients undergoing unrelated peripheral stem cell transplantation
ONKOLOGIE. 1999; 22(6): 519-519.
Doi: 10.1159/000027031
[OPEN ACCESS]
Web of Science
FullText
FullText_MUG
** Chopra, R; Eaton, D; Grassi, A; Shaw, B; Salat, C; Neumeister, P; Finazzi, G; Iacobelli, M; Prentice, G; Barbui, T
Defibrotide for the treatment of severe hepatic venoocclusive disease: Results of the European compassionate use study confirms safety and high response rate.
BLOOD 1999 94: 3129-3129.
Web of Science
** Gilli, R; Sipurzynski, S; Helmberg, W; Wagner, T; Schmidt, H; Neumeister, P; Linkesch, W; Lanzer, G
Amount of CD34+ cells in the peripheral blood - a real prediction for the yield of the stem cell concentrate?
BONE MARROW TRANSPLANT 1999 23: S214-S214.
Web of Science
** Mitterbauer, M; Brugger, S; Neumeister, P; Kalhs, P; Rabitsch, W; Loidolt, H; Keil, F; Hinterberger, W; Linkesch, W; Mannhalter, C; Mitterbauer, G; Greinix, H
Clinical and molecular disease eradication after allogeneic stem cell transplantation in patients with advanced non-Hodgkin's lymphoma.
BLOOD 1999 94: 4949-4949.
Web of Science
** Neumeister, P; Zinke, W; Schmidt, HH; Linkesch, W
Antithymocyte globulin may reduce transplant related mortality and chronic GVHD in patients undergoing allogeneic stem cell transplantation.
BONE MARROW TRANSPLANT 1999 23: S95-S95.
Web of Science
** Neumeister, P; Zinke, W; Schmidt, HH; Wagner, T; Linkesch, W
Life threatening bradycardia after infusion of cryopreserved stem cells.
BONE MARROW TRANSPLANT 1999 23: S177-S177.
Web of Science
** Zinke, W; Neumeister, P; Linkesch, W
Defibrotide - An approach in the treatment of severe hepatic veno-occlusive disease?
BONE MARROW TRANSPLANT 1999 23: S225-S225.
Web of Science
** Neumeister, P; Hiller, E; Gawaz, M; Holler, E; Kolb, HJ; Sill, H; Pihusch, R; Mempel, W; Wittmann, G; Salat, C
Changes in platelet membrane glycoproteins before bone marrow transplantation and after engraftment--a pilot study.
Eur J Med Res. 1998; 3(10): 465-469.
PubMed
** Schmidt, HH; Pirc-Danoewinata, H; Panzer-Grümayer, ER; Sill, H; Sedlmayr, P; Neumeister, P; Linkesch, W; Haas, OA
Translocation (3;5)(p26;q13) in a patient with chronic T-cell lymphoproliferative disorder.
Cancer Genet Cytogenet. 1998; 104(2):82-85
Doi: 10.1016/S0165-4608(97)00453-6
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
** Schmidt, HH; Neumeister, P; Kainer, F; Karpf, EF; Linkesch, W; Sill, H
Treatment of essential thrombocythemia during pregnancy: antiabortive effect of interferon-alpha?
Ann Hematol. 1998; 77(6):291-292
Doi: 10.1007%2Fs002770050461
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Jager, G; Neumeister, P; Hinterleitner, T; Hofler, G; Brezinschek, R; Linkesch, W
Cladribine (2-CDA) as a therapy for low-grade MALT-lymphoma: An organ-preserving therapeutic concept.
BLOOD 1998 92: 236B-237B.
Web of Science
** Schmidt, HH; Sill, H; Jager, G; Neumeister, P; Strunk, D; Linkesch, W
Capillary leak syndrome with late onset after autografting for multiple myeloma.
BONE MARROW TRANSPLANT 1998 21: S91-S91.
Web of Science
** Neumeister, P; Hoefler, G; Beham-Schmid, C; Schmidt, H; Apfelbeck, U; Schaider, H; Linkesch, W; Sill, H
Deletion analysis of the p16 tumor suppressor gene in gastrointestinal mucosa-associated lymphoid tissue lymphomas.
Gastroenterology. 1997; 112(6):1871-1875
Doi: 10.1053%2Fgast.1997.v112.pm9178679
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Neumeister, P; Linkesch, W; Höfler, G; Sill, H
2-Chlorodeoxyadenosine as first-line treatment in bronchus-associated lymphoid tissue lymphoma.
Blood. 1996; 87(8):3526-3526
Doi: 10.1182/blood.V87.8.3526a.bloodjournal8783526a
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Neumeister, P; Hofler, G; BehamSchmid, C; Schmidt, H; Apfelbeck, U; Linkesch, W; Sill, H
Homozygous deletions of the p16 gene in high-grade gastric malt lymphomas.
BLOOD 1996 88: 3311-3311.
Web of Science
** Salat, C; Holler, E; Reinhardt, B; Kolb, HJ; Pihusch, R; Neumeister, P; Hiller, E
Hypercoagulability in patients with veno-occlusive disease after bone marrow transplantation
Med Klin (Munich). 1994; 89(5): 245-247.
Web of Science
PubMed